|
1
|
Hwang JS and Rehan VK: Recent advances in
bronchopulmonary dysplasia: Pathophysiology, prevention, and
treatment. Lung. 196:129–138. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bancalari E and Jain D: Bronchopulmonary
dysplasia: 50 Years after the original description. Neonatology.
115:384–391. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Northway WH Jr, Rosan RC and Porter DY:
Pulmonary disease following respirator therapy of hyaline-membrane
disease. Bronchopulmonary dysplasia. N Engl J Med. 276:357–368.
1967.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen S, Wu Q, Zhong D, Li C and Du L:
Caffeine prevents hyperoxia-induced lung injury in neonatal mice
through NLRP3 inflammasome and NF-κB pathway. Respir Res.
21(140)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Principi N, Di Pietro GM and Esposito S:
Bronchopulmonary dysplasia: Clinical aspects and preventive and
therapeutic strategies. J Transl Med. 16(36)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sahni M and Bhandari V: Recent advances in
understanding and management of bronchopulmonary dysplasia.
F1000Res 9: F1000 Faculty Rev-703, 2020.
|
|
7
|
Thébaud B, Goss KN, Laughon M, Whitsett
JA, Abman SH, Steinhorn RH, Aschner JL, Davis PG, McGrath-Morrow
SA, Soll RF and Jobe AH: Bronchopulmonary dysplasia. Nat Rev Dis
Primers. 5(78)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lavoie PM and Dubé MP: Genetics of
bronchopulmonary dysplasia in the age of genomics. Curr Opin
Pediatr. 22:134–138. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Trembath A and Laughon MM: Predictors of
bronchopulmonary dysplasia. Clin Perinatol. 39:585–601.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Collaco JM, Romer LH, Stuart BD, Coulson
JD, Everett AD, Lawson EE, Brenner JI, Brown AT, Nies MK, Sekar P,
et al: Frontiers in pulmonary hypertension in infants and children
with bronchopulmonary dysplasia. Pediatr Pulmonol. 47:1042–1053.
2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu Y and Dong WB: Preventive effect of
caffeine on bronchopulmonary dysplasia in preterm infants. Zhongguo
Dang Dai Er Ke Za Zhi. 20:598–602. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
12
|
Bhandari A and Panitch HB: Pulmonary
outcomes in bronchopulmonary dysplasia. Semin Perinatol.
30:219–226. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Davidson LM and Berkelhamer SK:
Bronchopulmonary dysplasia: Chronic lung disease of infancy and
Long-Term pulmonary outcomes. J Clin Med. 6(4)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Postma DS, Bush A and van den Berge M:
Risk factors and early origins of chronic obstructive pulmonary
disease. Lancet. 385:899–909. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sucre J, Haist L, Bolton CE and
Hilgendorff A: Early changes and indicators characterizing lung
aging in neonatal chronic lung disease. Front Med (Lausanne).
8(665152)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pakvasa MA, Saroha V and Patel RM:
Optimizing caffeine use and risk of bronchopulmonary dysplasia in
preterm infants: A systematic review, Meta-analysis, and
application of grading of recommendations assessment, development,
and evaluation methodology. Clin Perinatol. 45:273–291.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Baud O and Watterberg KL: Prophylactic
postnatal corticosteroids: Early hydrocortisone. Semin Fetal
Neonatal Med. 24:202–206. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Askie LM, Davies LC, Schreiber MD, Hibbs
AM, Ballard PL and Ballard RA: Race effects of inhaled nitric oxide
in preterm infants: An individual participant data Meta-Analysis. J
Pediatr. 193:34–39.e2. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Thompson EJ, Greenberg RG, Kumar K,
Laughon M, Smith PB, Clark RH, Crowell A, Shaw L, Harrison L,
Scales G, et al: Association between furosemide exposure and patent
ductus arteriosus in hospitalized infants of very low birth weight.
J Pediatr. 199:231–236. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Augustine S, Cheng W, Avey MT, Chan ML,
Lingappa SM, Hutton B and Thébaud B: Are all stem cells equal?
Systematic review, evidence map, and meta-analyses of preclinical
stem cell-based therapies for bronchopulmonary dysplasia. Stem
Cells Transl Med. 9:158–168. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hellstrom A, Ley D, Hallberg B, Lofqvist
C, Hansen-Pupp I, Ramenghi LA, Borg J, Smith LE and Hard AL: IGF-1
as a drug for preterm infants: A Step-Wise clinical development.
Curr Pharm Des. 23:5964–5970. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang Z, Li W, Guo Q, Wang Y, Ma L and
Zhang X: Insulin-Like Growth Factor-1 Signaling in lung development
and inflammatory lung diseases. Biomed Res Int.
2018(6057589)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chetty A, Andersson S, Lassus P and
Nielsen HC: Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor
(IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol.
37:128–136. 2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Belcastro R, Lopez L, Li J, Masood A and
Tanswell AK: Chronic lung injury in the neonatal rat: Up-regulation
of TGFβ1 and nitration of IGF-R1 by peroxynitrite as likely
contributors to impaired alveologenesis. Free Radic Biol Med.
80:1–11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Banjac L, Kotur-Stevuljević J, Gojković T,
Bokan-Mirković V and Banjac G and Banjac G: Relationship between
insulin-like growth factor type 1 and intrauterine growth. Acta
Clin Croat. 59:91–96. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Salaets T, Aertgeerts M, Gie A, Vignero J,
de Winter D, Regin Y, Jimenez J, Vande Velde G, Allegaert K,
Deprest J and Toelen J: Preterm birth impairs postnatal lung
development in the neonatal rabbit model. Respir Res.
21(59)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dumpa V and Bhandari V: Surfactant,
steroids and non-invasive ventilation in the prevention of BPD.
Semin Perinatol. 42:444–452. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Day CL and Ryan RM: Bronchopulmonary
dysplasia: New becomes old again! Pediatr Res. 81:210–213.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Collaco JM and McGrath-Morrow SA:
Respiratory phenotypes for preterm infants, children, and adults:
Bronchopulmonary dysplasia and more. Ann Am Thorac Soc. 15:530–538.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bancalari E and Jain D: Bronchopulmonary
dysplasia: Can we agree on a definition? Am J Perinatol.
35:537–540. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jensen EA and Wright CJ: Bronchopulmonary
dysplasia: The ongoing search for one definition to rule them all.
J Pediatr. 197:8–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Philip AG: Chronic lung disease of
prematurity: A short history. Semin Fetal Neonatal Med. 14:333–338.
2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jobe AH and Bancalari E: Bronchopulmonary
dysplasia. Am J Respir Crit Care Med. 163:1723–1729.
2001.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jensen EA, Dysart K, Gantz MG, McDonald S,
Bamat NA, Keszler M, Kirpalani H, Laughon MM, Poindexter BB, Duncan
AF, et al: The diagnosis of bronchopulmonary dysplasia in very
preterm infants. An Evidence-based approach. Am J Respir Crit Care
Med. 200:751–759. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Islam JY, Keller RL, Aschner JL, Hartert
TV and Moore PE: Understanding the Short- and Long-Term respiratory
outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir
Crit Care Med. 192:134–156. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Haggie S, Robinson P, Selvadurai H and
Fitzgerald DA: Bronchopulmonary dysplasia: A review of the
pulmonary sequelae in the post-surfactant era. J Paediatr Child
Health. 56:680–689. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cox AM, Gao Y, Perl AT, Tepper RS and
Ahlfeld SK: Cumulative effects of neonatal hyperoxia on murine
alveolar structure and function. Pediatr Pulmonol. 52:616–624.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Niedermaier S and Hilgendorff A:
Bronchopulmonary dysplasia-an overview about pathophysiologic
concepts. Mol Cell Pediatr. 2(2)2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Balaji S, Dong X, Li H, Zhang Y, Steen E
and Lingappan K: Sex-specific differences in primary neonatal
murine lung fibroblasts exposed to hyperoxia in vitro: Implications
for bronchopulmonary dysplasia. Physiol Genomics. 50:940–946.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Choo-Wing R, Syed MA, Harijith A, Bowen B,
Pryhuber G, Janér C, Andersson S, Homer RJ and Bhandari V:
Hyperoxia and interferon-γ-induced injury in developing lungs occur
via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent
pathway. Am J Respir Cell Mol Biol. 48:749–757. 2013.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Teng RJ, Jing X, Michalkiewicz T, Afolayan
AJ, Wu TJ and Konduri GG: Attenuation of endoplasmic reticulum
stress by caffeine ameliorates hyperoxia-induced lung injury. Am J
Physiol Lung Cell Mol Physiol. 312:L586–L598. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Galán M, Kassan M, Kadowitz PJ, Trebak M,
Belmadani S and Matrougui K: Mechanism of endoplasmic reticulum
stress-induced vascular endothelial dysfunction. Biochim Biophys
Acta. 1843:1063–1075. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Pan J, Zhan C, Yuan T, Wang W, Shen Y, Sun
Y, Wu T, Gu W, Chen L and Yu H: Effects and molecular mechanisms of
intrauterine infection/inflammation on lung development. Respir
Res. 19(93)2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Laube M, Amann E, Uhlig U, Yang Y, Fuchs
HW, Zemlin M, Mercier JC, Maier RF, Hummler HD, Uhlig S and Thome
UH: Inflammatory mediators in tracheal aspirates of preterm infants
participating in a randomized trial of inhaled nitric oxide. PLoS
One. 12(e0169352)2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Savani RC: Modulators of inflammation in
bronchopulmonary dysplasia. Semin Perinatol. 42:459–470.
2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ghosh C and Wojtowycz M: Effect of
gestational disorders on preterm birth, low birthweight, and NICU
admission. Arch Gynecol Obstet. 303:419–426. 2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Papagianis PC, Pillow JJ and Moss TJ:
Bronchopulmonary dysplasia: Pathophysiology and potential
anti-inflammatory therapies. Paediatr Respir Rev. 30:34–41.
2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Cui TX, Brady AE, Fulton CT, Zhang YJ,
Rosenbloom LM, Goldsmith AM, Moore BB and Popova AP: CCR2 Mediates
Chronic LPS-Induced pulmonary inflammation and hypoalveolarization
in a murine model of bronchopulmonary dysplasia. Front Immunol.
11(579628)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Kalikkot Thekkeveedu R, Guaman MC and
Shivanna B: Bronchopulmonary dysplasia: A review of pathogenesis
and pathophysiology. Respir Med. 132:170–177. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kumar VH, Lakshminrusimha S, Kishkurno S,
Paturi BS, Gugino SF, Nielsen L, Wang H and Ryan RM: Neonatal
hyperoxia increases airway reactivity and inflammation in adult
mice. Pediatr Pulmonol. 51:1131–1141. 2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
D'Angio CT, Ambalavanan N, Carlo WA,
McDonald SA, Skogstrand K, Hougaard DM, Shankaran S, Goldberg RN,
Ehrenkranz RA, Tyson JE, et al: Blood cytokine profiles associated
with distinct patterns of bronchopulmonary dysplasia among
extremely low birth weight infants. J Pediatr. 174:45–51.e5.
2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Balany J and Bhandari V: Understanding the
impact of infection, inflammation, and their persistence in the
pathogenesis of bronchopulmonary dysplasia. Front Med (Lausanne).
2(90)2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Torchin H, Ancel PY, Goffinet F, Hascoët
JM, Truffert P, Tran D, Lebeaux C and Jarreau PH: Placental
complications and bronchopulmonary dysplasia: EPIPAGE-2 Cohort
Study. Pediatrics. 137(e20152163)2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Bhandari V and Lodha A: Is
bronchopulmonary dysplasia decided before birth? Pediatr Res.
87:809–810. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Pammi M, Lal CV, Wagner BD, Mourani PM,
Lohmann P, Luna RA, Sisson A, Shivanna B, Hollister EB, Abman SH,
et al: Airway microbiome and development of bronchopulmonary
dysplasia in preterm infants: A systematic review. J Pediatr.
204:126–133.e2. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Surate Solaligue DE, Rodríguez-Castillo
JA, Ahlbrecht K and Morty RE: Recent advances in our understanding
of the mechanisms of late lung development and bronchopulmonary
dysplasia. Am J Physiol Lung Cell Mol Physiol. 313:L1101–L1153.
2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Lewin G and Hurtt ME: Pre- and Postnatal
lung development: An updated species comparison. Birth Defects Res.
109:1519–1539. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Segerer FJ and Speer CP: Lung function in
childhood and adolescence: Influence of prematurity and
bronchopulmonary dysplasia. Z Geburtshilfe Neonatol. 220:147–154.
2016.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
59
|
Landry JS, Tremblay GM, Li PZ, Wong C,
Benedetti A and Taivassalo T: Lung function and bronchial
hyperresponsiveness in adults born prematurely. A Cohort study. Ann
Am Thorac Soc. 13:17–24. 2016.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Saarenpää HK, Tikanmäki M, Sipola-Leppänen
M, Hovi P, Wehkalampi K, Siltanen M, Vääräsmäki M, Järvenpää AL,
Eriksson JG, Andersson S and Kajantie E: Lung function in very low
birth weight adults. Pediatrics. 136:642–650. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kotecha SJ, Edwards MO, Watkins WJ,
Henderson AJ, Paranjothy S, Dunstan FD and Kotecha S: Effect of
preterm birth on later FEV1: A systematic review and meta-analysis.
Thorax. 68:760–766. 2013.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Salmon WD Jr and Daughaday WH: A
hormonally controlled serum factor which stimulates sulfate
incorporation by cartilage in vitro. J Lab Clin Med. 49:825–836.
1957.PubMed/NCBI
|
|
63
|
Dulak NC and Temin HM: A partially
purified polypeptide fraction from rat liver cell conditioned
medium with multiplication-stimulating activity for embryo
fibroblasts. J Cell Physiol. 81:153–160. 1973.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Rinderknecht E and Humbel RE: The amino
acid sequence of human insulin-like growth factor I and its
structural homology with proinsulin. J Biol Chem. 253:2769–2776.
1978.PubMed/NCBI
|
|
65
|
Bortvedt SF and Lund PK: Insulin-like
growth factor 1: Common mediator of multiple enterotrophic hormones
and growth factors. Curr Opin Gastroenterol. 28:89–98.
2012.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Piñeiro-Hermida S, López IP, Alfaro-Arnedo
E, Torrens R, Iñiguez M, Alvarez-Erviti L, Ruíz-Martínez C and
Pichel JG: IGF1R deficiency attenuates acute inflammatory response
in a bleomycin-induced lung injury mouse model. Sci Rep.
7(4290)2017.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Vitale G, Pellegrino G, Vollery M and
Hofland LJ: ROLE of IGF-1 system in the modulation of Longevity:
Controversies and new insights from a Centenarians' Perspective.
Front Endocrinol (Lausanne). 10(27)2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
López IP, Piñeiro-Hermida S, Pais RS,
Torrens R, Hoeflich A and Pichel JG: Involvement of Igf1r in
bronchiolar epithelial regeneration: Role during repair kinetics
after selective club cell ablation. PLoS One.
11(e0166388)2016.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Narasaraju TA, Chen H, Weng T, Bhaskaran
M, Jin N, Chen J, Chen Z, Chinoy MR and Liu L: Expression profile
of IGF system during lung injury and recovery in rats exposed to
hyperoxia: A possible role of IGF-1 in alveolar epithelial cell
proliferation and differentiation. J Cell Biochem. 97:984–998.
2006.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Moreno-Barriuso N, López-Malpartida AV, de
Pablo F and Pichel JG: Alterations in alveolar epithelium
differentiation and vasculogenesis in lungs of LIF/IGF-I double
deficient embryos. Dev Dyn. 235:2040–2050. 2006.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Liu JP, Baker J, Perkins AS, Robertson EJ
and Efstratiadis A: Mice carrying null mutations of the genes
encoding insulin-like growth factor I (Igf-1) and type 1 IGF
receptor (Igf1r). Cell. 75:59–72. 1993.PubMed/NCBI
|
|
72
|
Clement A and Eber E: Interstitial lung
diseases in infants and children. Eur Respir J. 31:658–666.
2008.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Li H, Batth IS, Qu X, Xu L, Song N, Wang R
and Liu Y: IGF-IR signaling in epithelial to mesenchymal transition
and targeting IGF-IR therapy: Overview and new insights. Mol
Cancer. 16(6)2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Günschmann C, Stachelscheid H, Akyüz MD,
Schmitz A, Missero C, Brüning JC and Niessen CM: Insulin/IGF-1
controls epidermal morphogenesis via regulation of FoxO-mediated
p63 inhibition. Dev Cell. 26:176–187. 2013.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Ahamed K, Epaud R, Holzenberger M, Bonora
M, Flejou JF, Puard J, Clement A and Henrion-Caude A: Deficiency in
type 1 insulin-like growth factor receptor in mice protects against
oxygen-induced lung injury. Respir Res. 6(31)2005.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Mourani PM, Mandell EW, Meier M, Younoszai
A, Brinton JT, Wagner BD, Arjaans S, Poindexter BB and Abman SH:
Early pulmonary vascular disease in preterm infants is associated
with late respiratory outcomes in childhood. Am J Respir Crit Care
Med. 199:1020–1027. 2019.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Li J, Masood A, Yi M, Lau M, Belcastro R,
Ivanovska J, Jankov RP and Tanswell AK: The IGF-I/IGF-R1 pathway
regulates postnatal lung growth and is a nonspecific regulator of
alveologenesis in the neonatal rat. Am J Physiol Lung Cell Mol
Physiol. 304:L626–L637. 2013.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hellström A, Ley D, Hansen-Pupp I,
Hallberg B, Löfqvist C, van Marter L, van Weissenbruch M, Ramenghi
LA, Beardsall K, Dunger D, et al: Insulin-like growth factor 1 has
multisystem effects on foetal and preterm infant development. Acta
Paediatr. 105:576–586. 2016.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hirsch K, Taglauer E, Seedorf G, Callahan
C, Mandell E, White CW, Kourembanas S and Abman SH: Perinatal
Hypoxia-Inducible factor stabilization preserves lung alveolar and
vascular growth in experimental bronchopulmonary dysplasia. Am J
Respir Crit Care Med. 202:1146–1158. 2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Higashi Y, Gautam S, Delafontaine P and
Sukhanov S: IGF-1 and cardiovascular disease. Growth Horm IGF Res.
45:6–16. 2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Stahl A, Connor KM, Sapieha P, Chen J,
Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin
KI, et al: The mouse retina as an angiogenesis model. Invest
Ophthalmol Vis Sci. 51:2813–2826. 2010.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Seedorf G, Kim C, Wallace B, Mandell EW,
Nowlin T, Shepherd D and Abman SH: rhIGF-1/BP3 preserves lung
growth and prevents pulmonary hypertension in experimental
bronchopulmonary dysplasia. Am J Respir Crit Care Med.
201:1120–1134. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Capoluongo E, Vento G, Ameglio F, Lulli P,
Matassa PG, Carrozza C, Santini SA, Antenucci M, Castagnola M,
Giardina B, et al: Increased levels of IGF-1 and
beta2-microglobulin in epithelial lining fluid of preterm newborns
developing chronic lung disease effects of rhG-CSF. Int J
Immunopathol Pharmacol. 19:57–66. 2006.PubMed/NCBI
|
|
84
|
Klevebro S, Hellgren G, Hansen-Pupp I,
Wackernagel D, Hallberg B, Borg J, Pivodic A, Smith L, Ley D and
Hellström A: Elevated levels of IL-6 and IGFBP-1 predict low serum
IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in
extremely preterm infants. Growth Horm IGF Res. 50:1–8.
2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Jin ZA, Jin ZY, Chi YX and Lu JR: Effects
of recombinant human insulin-like growth factor-1 on the expression
of Clara cell secretory protein in lung of hyperoxia-exposed
newborn rats. Zhonghua Er Ke Za Zhi. 45:369–373. 2007.PubMed/NCBI(In Chinese).
|
|
86
|
Guzmán-Bárcenas J, Calderón-Moore A,
Baptista-González H and Irles C: Clara cell protein expression in
mechanically ventilated term and preterm infants with respiratory
distress syndrome and at risk of bronchopulmonary dysplasia: A
Pilot study. Can Respir J. 2017(8074678)2017.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Löfqvist C, Niklasson A, Engström E,
Friberg LE, Camacho-Hübner C, Ley D, Borg J, Smith LE and Hellström
A: A pharmacokinetic and dosing study of intravenous insulin-like
growth factor-I and IGF-binding protein-3 complex to preterm
infants. Pediatr Res. 65:574–579. 2009.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Ley D, Hansen-Pupp I, Niklasson A,
Domellöf M, Friberg LE, Borg J, Löfqvist C, Hellgren G, Smith LE,
Hård AL and Hellström A: Longitudinal infusion of a complex of
insulin-like growth factor-I and IGF-binding protein-3 in five
preterm infants: Pharmacokinetics and short-term safety. Pediatr
Res. 73:68–74. 2013.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Chung JK, Hallberg B, Hansen-Pupp I,
Graham MA, Fetterly G, Sharma J, Tocoian A, Kreher NC, Barton N,
Hellström A and Ley D: Development and verification of a
pharmacokinetic model to optimize physiologic replacement of
rhIGF-1/rhIGFBP-3 in preterm infants. Pediatr Res. 81:504–510.
2017.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Ley D, Hallberg B, Hansen-Pupp I, Dani C,
Ramenghi LA, Marlow N, Beardsall K, Bhatti F, Dunger D, Higginson
JD, et al: rhIGF-1/rhIGFBP-3 in preterm infants: A Phase 2
Randomized Controlled Trial. J Pediatr. 206:56–65.e8.
2019.PubMed/NCBI View Article : Google Scholar
|
